Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Benvenuti

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Cellular Physiology|July 4, 2007
The MET receptor tyrosine kinase in invasion and metastasisSilvia Benvenuti, Paolo M Comoglio
FEBS Letters|March 15, 2005
Identification of cancer genes by mutational profiling of tumor genomesSilvia Benvenuti, Sabrina Arena, Alberto Bardelli
Cancer Biology & Therapy|October 7, 2004
PRL-3: a phosphatase for metastasis?Jason A Sager, Silvia Benvenuti, Alberto Bardelli
Expert Opinion on Investigational Drugs|September 28, 2010
Targeting the MET oncogene in cancer and metastasesGiulia M Stella, Silvia Benvenuti, Paolo M Comoglio
Cancers|July 24, 2019
Lung-Seeking MetastasesGiulia M Stella, Stefan Kolling, Silvia Benvenuti, et al.
Proteomics|November 8, 2002
Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identificationKetan Patel, Rob Stein, Silvia Benvenuti, et al.
Ebiomedicine|October 18, 2017
MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary OriginGiulia M Stella, Silvia Benvenuti, Alessandra Gentile, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutationAnna Rita Virzì, Alessandra Gentile, Silvia Benvenuti, et al.
Cancer Research|April 14, 2011
Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesisAlessandra Gentile, Luca Lazzari, Silvia Benvenuti, et al.
International Journal of Cancer|April 8, 2014
The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cellsAlessandra Gentile, Luca Lazzari, Silvia Benvenuti, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Cellular Physiology|July 4, 2007
The MET receptor tyrosine kinase in invasion and metastasisSilvia Benvenuti, Paolo M Comoglio
FEBS Letters|March 15, 2005
Identification of cancer genes by mutational profiling of tumor genomesSilvia Benvenuti, Sabrina Arena, Alberto Bardelli
Cancer Biology & Therapy|October 7, 2004
PRL-3: a phosphatase for metastasis?Jason A Sager, Silvia Benvenuti, Alberto Bardelli
Expert Opinion on Investigational Drugs|September 28, 2010
Targeting the MET oncogene in cancer and metastasesGiulia M Stella, Silvia Benvenuti, Paolo M Comoglio
Cancers|July 24, 2019
Lung-Seeking MetastasesGiulia M Stella, Stefan Kolling, Silvia Benvenuti, et al.
Proteomics|November 8, 2002
Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identificationKetan Patel, Rob Stein, Silvia Benvenuti, et al.
Ebiomedicine|October 18, 2017
MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary OriginGiulia M Stella, Silvia Benvenuti, Alessandra Gentile, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutationAnna Rita Virzì, Alessandra Gentile, Silvia Benvenuti, et al.
Cancer Research|April 14, 2011
Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesisAlessandra Gentile, Luca Lazzari, Silvia Benvenuti, et al.
International Journal of Cancer|April 8, 2014
The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cellsAlessandra Gentile, Luca Lazzari, Silvia Benvenuti, et al.
Pageof 4